Novartis invests in Seventure microbiome fund

Seventure Partners closed its Health for Life Capital fund at EUR 160 million ($175.3 million), with Novartis AG (NYSE:NVS; SIX:NOVN) as a new investor. Seventure President and CEO Isabelle de Cremoux said Novartis invested "tens of millions" of euros, but declined to give an exact amount. Seventure said Bpifrance also invested in the fund, which targets the microbiome, nutrition, biotech and digital health sectors. ...